We are live on
!
Find out more
KTC
Kistler-Tiffany Companies Portfolio holdings
AUM
$616M
1-Year Est. Return
16.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.5%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$264M
AUM Growth
+$912K
(+0.35%)
Cap. Flow
-$1.34M
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
50.97%
Holding
615
New
36
Increased
119
Reduced
95
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$3.36M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$664K |
| 3 |
Crown Holdings
CCK
|
+$571K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$445K |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$417K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mesa Laboratories
MLAB
|
+$6.49M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.35M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$733K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$561K |
| 5 |
Vanguard Morningstar Value ETF
VTV
|
+$438K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.67% |
| 2 | Technology | 6.15% |
| 3 | Consumer Staples | 4.82% |
| 4 | Communication Services | 4.41% |
| 5 | Financials | 4.17% |
Similar funds
FANJ
NWM
KC
EWM
SAM
TWI
TF
ECI
Kistler-Tiffany Companies's Q3 2019 Portfolio in Review
As of Q3 2019, Kistler-Tiffany Companies held 615 positions worth $264M, up 0.35% from $263M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Kistler-Tiffany Companies's Q3 2019 filing shows 36 new, 119 increased, 95 reduced and 19 closed positions. Its largest new stake was Crown Holdings: 8,915 shares worth $589K. The largest sale was Mesa Laboratories, an estimated $6.49M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Staples.
- Kistler-Tiffany Companies's largest Q3 2019 buy was Crown Holdings: 8,915 shares worth $589K.
- Kistler-Tiffany Companies added most to West Pharmaceutical in Q3 2019, an estimated $3.36M increase.
- Kistler-Tiffany Companies's biggest Q3 2019 reduction was Mesa Laboratories, cutting an estimated $6.49M.
- Kistler-Tiffany Companies fully exited Invesco S&P MidCap 400 Pure Growth ETF in Q3 2019, selling an estimated $336K.
- Kistler-Tiffany Companies's ten largest holdings make up 51% of its $264M portfolio in Q3 2019.
- Kistler-Tiffany Companies opened 36 new positions and closed 19 in Q3 2019.
- Kistler-Tiffany Companies's portfolio value rose 0.35% quarter-over-quarter to $264M.
Based on Kistler-Tiffany Companies's 13F filing for Q3 2019, filed 18 Oct 2019.